| Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised … B Burtness, KJ Harrington, R Greil, D Soulières, M Tahara, G de Castro, ... The Lancet 394 (10212), 1915-1928, 2019 | 2699 | 2019 |
| Molecular classification identifies a subset of human papillomavirus–associated oropharyngeal cancers with favorable prognosis PM Weinberger, Z Yu, BG Haffty, D Kowalski, M Harigopal, J Brandsma, ... Journal of clinical oncology 24 (5), 736-747, 2006 | 965 | 2006 |
| Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised … NY Lee, RL Ferris, A Psyrri, RI Haddad, M Tahara, J Bourhis, K Harrington, ... The Lancet Oncology 22 (4), 450-462, 2021 | 422 | 2021 |
| Human papillomavirus in cervical and head-and-neck cancer A Psyrri, D DiMaio Nature clinical practice oncology 5 (1), 24-31, 2008 | 407 | 2008 |
| Immunotherapy for pancreatic cancer: A 2020 update D Schizas, N Charalampakis, C Kole, P Economopoulou, E Koustas, ... Cancer treatment reviews 86, 102016, 2020 | 384 | 2020 |
| Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, DC DJ Adelstein, JA Ridge, ML Gillison, AK Chaturvedi, G D'Souza, ... Head & neck 31 (11), 2009 | 356 | 2009 |
| E6 and E7 gene silencing and transformed phenotype of human papillomavirus 16–positive oropharyngeal cancer cells T Rampias, C Sasaki, P Weinberger, A Psyrri Journal of the National Cancer Institute 101 (6), 412-423, 2009 | 331 | 2009 |
| Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis A Psyrri, Z Yu, PM Weinberger, C Sasaki, B Haffty, R Camp, D Rimm, ... Clinical Cancer Research 11 (16), 5856-5862, 2005 | 322 | 2005 |
| Granulosa cell tumor of the ovary D Pectasides, E Pectasides, A Psyrri Cancer treatment reviews 34 (1), 1-12, 2008 | 311 | 2008 |
| Beyond BRCA: new hereditary breast cancer susceptibility genes P Economopoulou, G Dimitriadis, A Psyrri Cancer treatment reviews 41 (1), 1-8, 2015 | 300 | 2015 |
| The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications P Economopoulou, C Perisanidis, EI Giotakis, A Psyrri Annals of translational medicine 4 (9), 2016 | 296 | 2016 |
| Oral squamous cell cancer: early detection and the role of alcohol and smoking AG Zygogianni, G Kyrgias, P Karakitsos, A Psyrri, J Kouvaris, N Kelekis, ... Head & neck oncology 3, 1-12, 2011 | 293 | 2011 |
| Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management A Psyrri, S Papageorgiou, T Economopoulos Annals of Oncology 19 (12), 1992-1999, 2008 | 258 | 2008 |
| Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab … JB Vermorken, A Psyrri, R Mesia, F Peyrade, F Beier, B De Blas, I Celik, ... Annals of oncology 25 (4), 801-807, 2014 | 242 | 2014 |
| Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study KJ Harrington, B Burtness, R Greil, D Soulières, M Tahara, G de Castro Jr, ... Journal of Clinical Oncology 41 (4), 790-802, 2023 | 222 | 2023 |
| Evaluation of PD-L1 expression and associated tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma M Vassilakopoulou, M Avgeris, V Velcheti, V Kotoula, T Rampias, ... Clinical Cancer Research 22 (3), 704-713, 2016 | 219 | 2016 |
| Biomarkers for immunotherapy response in head and neck cancer N Gavrielatou, S Doumas, P Economopoulou, PG Foukas, A Psyrri Cancer treatment reviews 84, 101977, 2020 | 215 | 2020 |
| Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer A Psyrri, M Kassar, Z Yu, A Bamias, PM Weinberger, S Markakis, ... Clinical Cancer Research 11 (24), 8637-8643, 2005 | 203 | 2005 |
| Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma A Strati, G Koutsodontis, G Papaxoinis, I Angelidis, M Zavridou, ... Annals of Oncology 28 (8), 1923-1933, 2017 | 202 | 2017 |
| Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer PM Weinberger, Z Yu, BG Haffty, D Kowalski, M Harigopal, C Sasaki, ... Clinical Cancer Research 10 (17), 5684-5691, 2004 | 196 | 2004 |
